Summit Therapeutics recently reported weaker Q3 2025 results, with a wider EBITDA loss and deteriorating EPS that added pressure to its ongoing turnaround efforts. In contrast to the softer earnings ...
Shares from a private placement that took place before American Bitcoin merged with Gryphon Digital Mining Inc. became ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback